Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 457-460

  Fiad, Tarek M ^a   Cunningham, Sean K ^a   Hayes, Frances J ^a   McKenna, T Joseph ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CALCIUM TRANSPORT; CLINICAL ARTICLE; DRUG EFFECT; EXTRACELLULAR CALCIUM; FEMALE; HUMAN; HYPERTENSION; MALE; NATRIURESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BALANCE; VASCULAR SMOOTH MUSCLE;

AGED; ALDOSTERONE; BLOOD PRESSURE; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; REFERENCE VALUES; RENIN; RENIN-ANGIOTENSIN SYSTEM; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

ANGINA; STAPHYLOCOCCUS PHAGE 187;

EID: 0031023291     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.457     Document Type: Article

References (22)

1. Fleckenstein A. 1983 History of calcium antagonists. Circ Res. 52(Suppl 1):3-16.
2. Kiowski W, Erne P, Bertel O, Hulthen UL, Ritz R, Buhler FR. 1983 Unchanged baroreflex sensitivity during acute and chronic antihypertensive therapy with nifedipine. J Hypertens. 1(Suppl 2):365-367.
3. Lund-Johansen P, Omvik P. 1983 Hemodynamic effects of nifedipine in essential hypertension at rest and during exercise. J Hypertens. 1:159-163.
4. Swanson DR, Barclay BL, Wong PSL, Theeuwes F. 1987 Nifedipine gastrointestinal therapeutic system. Am J Med. 83(Suppl 6B):3-9.
5. Chung M, Reitberg DP, Gaffney M, Singleton W. 1987 Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine. Am J Med. 83(Suppl 6B):10-14.
6. Cappuccio FP, Markandu ND, Sagnella GA, et al. 1991 Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med. 91:233-238.
7. Pevahouse JB, Markandu ND, Cappuccio FP, Buckley MG, Sagnella GA, MacGregor GA. 1990 Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure. Br Med J. 301:580-584.
8. Barnett RQ, Bollag WB, Isales CM, McCarthy RT, Rasmussen H. 1989 Role of calcium in angiotensin II-mediated aldosterone secretion. Endocr Rev. 10:496-518.
9. Radke KJ, Glendenin RE, Taylor RE, Schneider EG. 1989 Calcium dependence of osmolarity, potassium, and angiotensin II-induced aldosterone secretion. Am J Physiol. 256:E760-E764.
10. Fitzpatrick SC, McKenna TJ. 1992 Evidence for a tonic inhibitory role of nifedipine-sensitive calcium channels in aldosterone biosynthesis. J Steroid Biochem Mol Biol. 42:575-580.
11. Sequeira SJ, Loughlin T, Cunningham SK, et al. 1986 Evaluation of an aldosterone radioimmunoassay: the renin-angiotensin-aldosterone axis as a function of sex and age. Ann Clin Biochem. 23:65-75.
12. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham SK. 1991 Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab. 73:952-957.
13. Bellini G, Battilana G, Puppis E, et al. 1984 Renal response to acute nifedipine administration in normotensive and hypertensive patients during normal and low salt intake. Curr Ther Res. 35:974-981.
14. Shigematsu S, Yamada T, Aizawa T, Takasu N, Shimizu Z. 1992 Differential effects of nifedipine on plasma atrial natriuretic peptide in normal subjects and hypertensive patients. Angiology. 43:40-46.
15. Krishna GG, Riley LJ, Deuter G, Kapoor SC, Narins RG. 1991 Natriuretic effect of calcium-channel blockers in hypertensives. Am J Kidney Dis. 18:566-572.
16. Martin AM, Simon MAQ, Extremera BG, Garcia MA, Martinez MR, Luengo MRM. 1992 Metabolic and antihypertensive effects of nifedipine in hypertensive patients. J Cardiovasc Pharmacol. 19(Suppl 2):S57-S59.
17. Colantonio D, Casale R, Desiati P, Giandomenico G, Bucci V, Pasqualetti P. 1991 Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension. J Clin Pharmacol. 31:238-242.
18. Larochelle P. 1992 Renal tubular effects of calcium antagonists. Kidney Int. 41(Suppl 36):49-53.
19. Nadler JL, Hsueh W, Horton R. 1985 Therapeutic effect of calcium channel blockade in primary aldosteronism. J Clin Endocrinol Metab. 60:396-899.
20. Hiramatsu K, Yamagishi F, Kubota T, Yamada T. 1982 Acute effects of calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension. Am Heart J. 104:1346-1350.
21. Goldberg AI, Dunlay MC, Sweet CS. 1995 Safety and tolerability of losartan potassium, an angiotensin II receptor antangonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol. 75:793-795.
22. Goodfriend TL, Elliot ME, Catt KJ. 1996 Angiotensin receptors and their antagonists. N Engl J Med. 334:1649-1654.